Plicamycin in pregnancy and breastfeeding

Plicamycin]]>

Risk Factor: XM
Class: Antineoplastics

Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References

Fetal Risk Summary

No reports on the use of plicamycin (formerly named mithramycin) during pregnancy have been located. Occupational exposure of the mother to antineoplastic agents during pregnancy may present a risk to the fetus. A position statement from the National Study Commission on Cytotoxic Exposure and a research article involving some antineoplastic agents are presented in the monograph for cyclophosphamide (see Cyclophosphamide).

Breast Feeding Summary

No data are available.

Please enable JavaScript to view the comments powered by Disqus.blog comments powered by Disqus